Related references
Note: Only part of the references are listed.The Inflammasomes: Guardians of the Body
Fablo Martinon et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Contribution of Adenosine A2B Receptors to Inflammatory Parameters of Experimental Colitis
Julia-Stefanie Frick et al.
JOURNAL OF IMMUNOLOGY (2009)
Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry
Rikke Leth-Larsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Inhibition of Siah ubiquitin ligase function
A. Moller et al.
ONCOGENE (2009)
Selective Deletion of the A1 Adenosine Receptor Abolishes Heart-Rate Slowing Effects of Intravascular Adenosine In Vivo
Michael Koeppen et al.
PLOS ONE (2009)
Adenosine receptors in regulation of dendritic cell differentiation and function
Sergey V. Novitskiy et al.
BLOOD (2008)
Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
Michail V. Sitkovsky et al.
CLINICAL CANCER RESEARCH (2008)
IFN-β regulates CD73 and adenosine expression at the blood-brain barrier
Jussi Niemela et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
CD73 participates in cellular multiresistance program and protects against TRAIL-Induced apoptosis
Andrey Mikhailov et al.
JOURNAL OF IMMUNOLOGY (2008)
CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes
Masahide Takedachi et al.
JOURNAL OF IMMUNOLOGY (2008)
The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation
Luci Bavaresco et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Integrin-mediated Protein Kinase A Activation at the Leading Edge of Migrating Cells
Chinten J. Lim et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases
Gyorgy Hasko et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Patrizia Pellegatti et al.
PLOS ONE (2008)
Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response
John Stagg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis
Jeffrey H. Mills et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells
Li Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
A2B adenosine receptor dampens hypoxia-induced vascular leak
Tobias Eckle et al.
BLOOD (2008)
RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion
Xiuling Zhi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors
Yu Chen et al.
SCIENCE (2006)
Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF-1α
Cynthia Lee Richard et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Human sebaceous tumors harbor inactivating mutations in LEF1
H Takeda et al.
NATURE MEDICINE (2006)
Expression of CD73 and its ecto-5′-nucleotidase activity are elevated in papillary thyroid carcinomas
T Kondo et al.
HISTOPATHOLOGY (2006)
Ecto-5 '-nucleotidase (eN, CD73) is coexpressed with metastasis promoting antigens in human melanoma cells
R. Sadej et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2006)
Combined affinity labelling and mass spectrometry analysis of differential cell surface protein expression in normal and prostate cancer cells
C Hastie et al.
ONCOGENE (2005)
Role of estrogen receptor in the regulation of ecto-5′-nucleotidase and adenosine in breast cancer
J Spychala et al.
CLINICAL CANCER RESEARCH (2004)
Crucial role for ecto-5-′nucleotidase (CD73) in vascular leakage during hypoxia
LF Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells - Implications for cancer cell behavior
EY Tan et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation
K Fukuda et al.
BRITISH JOURNAL OF CANCER (2004)
Gene expression profiling of tumor xenografts:: In vivo analysis of organ-specific metastasis
H Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Spatial restriction of α4 integrin phosphorylation regulates lamellipodial stability and α4β1-dependent cell migration
LE Goldfinger et al.
JOURNAL OF CELL BIOLOGY (2003)
Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia
K Synnestvedt et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
CD39 is the dominant Langerhans cell associated ecto-NTPDase:: Modulatory roles in inflammation and immune responsiveness
N Mizumoto et al.
NATURE MEDICINE (2002)
Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection
J Linden
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism
L Airas et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
